Novant Health’s Post

Ever wonder when you should start to consider termination of resuscitation efforts? Zachary Boivin and the UConn/HH EM team put a ton of effort into a massive amount of data collection, analysis, and reconciliation. We hope it's valuable and applicable for everyone. Please check out our article below describing real-world epinephrine use, associated patient level outcomes, and subgroup analysis by age, total epinephrine dose, and more! Most notable for me, patients with shockable rhythms, including refractory VT/VF and storm, are receiving as much (maybe more?) epinephrine than other subgroups, and epinephrine use is similar across subgroups regardless of age with some difference in both directions relating to comorbidities. Is there room in our practice for more judicious use of epinephrine in cardiac arrest? Proud to have been involved in this publication! https://lnkd.in/gSpxsjdJ

At the #AHA23 late-breaking session “Heart Failure – VADS, Kids, and Money,” Stephen Greene discussed how patient outcomes can be improved by treating heart failure with a greater sense of urgency, more efficient trial enrollment, and a focus on implementation. Read more on his and other DCRI faculty’s time at AHA 2023 here: https://lnkd.in/gTzBWcCY #clinicaltrials #clinicalresearch #heartfailure #hearthealth

Study after study--let's make this standard practice! Better patient outcomes with cost savings is a win-win https://lnkd.in/eJ6tQju9

New from American Thoracic Society: ATS 2023 Clinical Year in Review Bundle https://lnkd.in/dURajQ8i

Venous conditions can significantly impact an individual’s quality of life, causing pain, discomfort, and limitations in daily activities. In the following blog post, we explore the positive benefits and improved quality of life experienced by patients after receiving venous treatment at The Whiteley Clinic for these various conditions. https://lnkd.in/efu-HY8Z

ILWTI CEO Brandy McKeown, ILWTI Director or Compression Suzie Ehmann and Runzun ShetyeRunjhun Retarekar are presenting a virtual webinar designed to get practioners thinking outside the traditional Lymphedema box. Learn about the application of lymphedema techniques to varying diagnosis!

Learn about the advantages of in-hospital initiation of guideline-directed medical therapy for heart failure, supported by the STRONG-HF and SCORED-WHF trials. For more details, check out this video featuring Deepak Bhatt, MD, MPH, Director of Mount Sinai Heart: https://ow.ly/aZmE50QzEAO

"Simply put, without the "Berlin Heart", he would have died two or three days later." Words of a mother who almost lost her child. Her son Luca, who was born with a univentricular heart and suffered from a failing Fontan circulation, was saved by the EXCOR® Revive Ventricular Assistant Device System. Luca, 17 at the time, needed a heart transplant but was removed from the list due to Fontan palliation issues. He was weak, immobile, and had severe health problems. With his doctors and family, Luca opted for EXCOR® Revive, which significantly improved his condition. He made it back on the transplant list and became increasingly active. After 132 days on EXCOR® Revive, he successfully received a donor heart. In 2022´s Berlin Heart summer event, we had the great honor to celebrate with Luca and his family. We also showed them around our production facilities and had the opportunity to talk about his experience with the “Berlin Heart”. See the moving interview below and on Youtube: https://lnkd.in/dsFAMZ-i #failingfontan #ourpatientsourmission #VAD LMU Klinikum München, Fontanherzen eV, Steffi Sänger, Oliver Päßler, BIOCOM Interrelations GmbH, Kinderkardiologie und Pädiatrische Intensivmedizin, LMU Klinikum ++++++++++ The access to some or all shown products may be restricted due to country-specific regulatory approvals. IKUS and EXCOR Active are intended for professional healthcare facility environments only.   The use of EXCOR® VAD for adults, RVAD-support, EXCOR® Blood pumps with bileaflet valves, EXCOR® Venous Cannula, EXCOR® Arterial Cannula for Graft, Caddy quattro kit as well as Excor mobile is not FDA approved. EXCOR® Active is an investigational device approved for use in a clinical study under IDE# G200252 approved by the FDA.

❤️ February is American Heart Month ❤️ Did you know that according to the CDC, someone has a heart attack every 40 seconds? The American Heart Association and the American College of Cardiology set the standards for care for acute coronary syndromes. ⏱ Time is of the essence when it comes to treatment. When I was in nursing school more than a dozen years ago, we used the acronym MONA ✔ Morphine ✔ Oxygen ✔ Nitrates ✔ Aspirin This still applies, but now I know there are so many other pieces that need to fall into place. When a patient has chest pain in the hospital or is brought to the ER, a protocol is triggered. This protocol reflects the ACC/AHA guidelines. As healthcare providers, we have a limited amount of time to make the most impact for these patients.    Our goals are: >30 minutes door-to-needle time for administration of fibrinolytic (clot-busting) medication >90 minutes door-to-balloon time for primary PCI (cardiac catheterization with stent) There are so many people who play a role in these two seemingly simple goals. If you have any questions about what else goes into treatment of acute coronary syndromes, please reach out. ☎ 973.879.2782 📩 [email protected]

The available evidence is quite clear: video laryngoscopy is better for patients than direct laryngoscopy, and our patients deserve the best available care we can provide. There are too many good VL systems on the market to claim that your system can't find one to field in your ALS/MICU units, and several of them use the same blade geometries you're already carrying for DL. Train your people to set up VL, then execute DL unless a good view cannot be quickly established. If you do that first lift, a small shuffle, and a second lift and you don't have a Grade II or better view, then move your gaze from the throat to the camera's view and proceed under VL. It's genuinely no more complicated than that.